US Market Report for Neurovascular Stents 2017 - MedCore

  • ID: 3960409
  • Report
  • Region: United States
  • 79 pages
  • iData Research
1 of 5

FEATURED COMPANIES

  • Boston Scientific
  • Codman & Shurtleff
  • Cyberonics
  • InoMed
  • Integra LifeSciences
  • Medtronic
  • MORE
High single digit market growth will be seen throughout the forecast period for neurovascular stents as next generation devices continue to enter the U.S. market. Traditional coil assisted stenting will continue to grow in unit sales while flow diversion stenting, a new and promising endovascular treatment, will experience rapid growth as well. Sales of these devices in the U.S. only began in 2011 following the approval of the Pipeline™ device from Medtronic. Flow diversion stents have the potential to cannibalize a portion of traditional stent sales but they will both continue to experience growth.

These increases in unit sales will also be driven by innovation in these devices making them smaller and able to place in more distal locations. The high market value is in part attributable to the fact that flow diversion stents command an ASP of nearly twice that of a traditional stent. Both types of stents are expected to experience marginal increases in pricing due to innovation, which will also drive market growth.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Boston Scientific
  • Codman & Shurtleff
  • Cyberonics
  • InoMed
  • Integra LifeSciences
  • Medtronic
  • MORE
Table Of Contents I
List Of Figures Ix
List Of Charts Xi
Executive Summary
U.S. Neuromodulation, Neurovascular, Neurosurgical And Monitoring Device Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History
Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring
Disease Overview
2.1 Basic Anatomy
2.2 Disease Pathology And Disorders
2.2.1 Introduction
2.2.2 General Diagnostics And Neurosurgery
2.2.3 Tumor And Brain Cancer
2.2.4 Brain Arteriovenous Malformations
2.2.5 Ischemic Stroke
2.2.6 Brain Aneurysm
2.2.7 Disorders Related To Cerebrospinal Fluids And Intracranial Pressure
2.2.7.1 Hydrocephalus And Intracranial Pressure Disorder
2.2.7.2 Cerebral Edema
2.2.8 Indication For Neuromodulation
2.2.9 Traumatic Brain Injury
Product Assessment
3.1 Product Portfolios
3.1.1 Neurovascular Stent
3.1.1.1 Introduction
3.1.1.2 Product Matrix For Neurovascular Stent Market: Core Companies
3.2 Regulatory Issues And Recalls
3.2.1 Neurovascular Stent
3.3 Clinical Trials
3.3.1 Neurovascular Stent
Neurovascular Stent Market
4.1 Introduction
4.2 Market Overview
4.3 Market Analysis And Forecast
4.3.1 Total Neurovascular Stent Market
4.3.2 Traditional Neurovascular Stent Market
4.3.3 Flow Diversion Stent Market
4.4 Drivers And Limiters
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 Competitive Market Share Analysis
Abbreviations
Appendix: Company Press Releases
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Boston Scientific
  • Codman & Shurtleff
  • Cyberonics
  • InoMed
  • Integra LifeSciences
  • Medtronic
  • MORE
There are two main types of neurovascular stents currently on the market, the traditional stent and the flow diverter stent. They are both used as treatments for cerebral aneurysms. Traditional neurovascular stents are small, flexible, tube-like devices used for stabilizing detachable coils within an aneurysm. They serve to block off the aneurysm and to prevent coils from slipping back into the main blood vessel. These stents are also used to treat intracranial stenosis by opening blocked arteries. These stents are delivered in reduced tube structures for easier navigation and delivery through the narrow intracranial vessels. As brain arteries are more fragile than carotid arteries, a self-expanding stent that gently opens to the desired vessel diameter is generally used. Self-expandable stents carry a lower risk of dissection or vessel rupture when compared to the balloon-expandable stents.
Note: Product cover images may vary from those shown
5 of 5
Medtronic
Boston Scientific
St. Jude Medical
Cyberonics
Codman & Shurtleff
Stryker
Integra LifeSciences
InoMed
Mizuho America
RauMedic
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll